PFIZER TOPS ESTIMATES, HIKES LOW END OF REVENUE GUIDANCE ON STRENGTH OF ELIQUIS, OTHER DRUGS - CNBC

Earnings beat and guidance hike on non-Covid strength signal corporate momentum.